The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 20,000 employees and 60 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. From drug discovery and development to manufacturing and diagnostics, MilliporeSigma is dedicated to read moresolving the toughest problems in life science by collaborating with the global scientific community. MilliporeSigma's products range from lab water systems to gene-editing tools, antibodies, cell lines and end-to-end systems to manufacture drugs. MilliporeSigma works closely with its customers from academia, biotech and pharma to help deliver the promise of making their work better, faster and safer. [website]

Minakem is a manufacturer of fine chemicals, pharmaceutical intermediates and (APIs). Today, the leading pharmaceutical and biopharmaceutical companies rely on Minakem’s strong technology platforms to manufacture high-profile proprietary compounds and develop innovative processes to add significant value within their supply chain.

Minakem has a long read moredistinguished history providing clients with cGMP intermediates, complex fine chemicals, API’s, Generics, contract services for the pharmaceutical and life science industries. Minakem operates three FDA approved sites in France and Germany. These facilities provide a full range of complementary technologies and services to the pharmaceutical industry for small, medium and large volumes of complex, regulated intermediates and APIs.

Moehs Group is a well established and reputated European API manufacturer and CMDO provider. Our company offers a solid platform for the development and production for third-parties of any kind of synthetic Small Molecules, either APIs or Intermediates.

Our Research Center starts development with few grams read morein the laboratory and progresses to batches of 1-2 Kg in the GMP certified Kilo lab and the range of 5-100Kg in our GMP Pilot Plant. Processes may be further scaled-up in our 7 European Manufacturing sites to hundreds of kilos batch size.

Our Research Center also offers development and manufacturing services of High Potent APIs from grams to 1-2Kg.

In terms of Analytical development and testing, our company offers analytical method development, validation and transfer services as long as GMP release testing. Our sites are equipped with the most state-of-the-art physico-chemical analytical equipment, including genotoxic impurities and nitrosamines testing.

All our sites are FDA approved, hold current EU GMP Certificate and run under a corporate common Quality Policy.

Supporting CMC services are also available. Our Regulatory Affairs team has experience on submissions all around the world, including EU, FDA, Brazil, China, Korea, among others.

Expert IP support is also available with internal resources for patent assessment and strategy.

Over its 35 year history, Moravek Biochemicals & Radiochemicals has successfully completed over 2,000 custom carbon-14 radiolabeling projects, with a 99% rate of success. Custom synthesis is carried out by an exceptionally capable team including 9 Ph.D. and 7 M.Sc. radiochemists. We manufacture APIs and Drug Products under Drug Manufacturing License from read moreCalifornia Department of Public Health and have passed quality audits by Merck and other major pharmaceutical companies with no observed violations.

Custom labeling, custom synthesis, custom radiolabeling, cGMP, GMP, GLP, Radiochemistry, Radiolabeling, Radiochemicals, carbon-14, C14, tritium labeling, tritiation, radiochemistry, radiosynthesis, API, active pharmaceutical ingredients, clinical trials, 3H, drug product, analysis, analytical, radio-GMP, radio-cGMP. [website]